Inspire Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
81.41 Mil |
| Income |
-47.12 Mil |
| Net Profit Margin |
-57.88% |
| Return on Equity |
-54.56% |
| Debt/Equity Ratio |
0.25 |
|
| Revenue/Share |
1.35 |
| Earnings/Share |
-0.80 |
| Book Value/Share |
1.46 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 14.3 | 9.7 | 7.2 |
| 2nd Qtr | 23.1 | 22.0 | 15.4 |
| 3rd Qtr | 25.2 | 20.0 | 12.2 |
| 4th Qtr | NA | 18.9 | 13.9 |
| Total | 62.5 | 70.5 | 48.7 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.34 | -$0.46 | -$0.62 |
| 2nd Qtr | -$0.17 | -$0.11 | -$0.14 |
| 3rd Qtr | -$0.12 | -$0.17 | -$0.32 |
| 4th Qtr | NA | -$0.17 | -$0.51 |
| Total | -$0.63 | -$0.91 | -$1.59 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -100% | 10% | --- |
| 2nd Qtr | 50% | 76% | 77% |
| 3rd Qtr | 29% | -55% | -129% |
| 4th Qtr | NA | 0% | -59% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 26% | 26% |
| 2nd Qtr | -55% | 21% |
| 3rd Qtr | 29% | 47% |
| 4th Qtr | NA | 67% |
advertisement
Recent News